| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;111:2418-2423.)
© 2005 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
From Brigham and Womens Hospital and Harvard Medical School (M.O.S.), Boston, Mass; Duke Clinical Research Institute and Duke University Medical Center (A.S.H., K.L.L.), Durham, NC; and Mt. Sinai Medical Center (G.A.L.), Miami, Fla.
Correspondence to Michael O. Sweeney, MD, Cardiac Arrhythmia Service, Brigham and Womens Hospital, 75 Francis St, Boston, MA 02115. E-mail mosweeney{at}partners.org
Received July 28, 2004; revision received November 12, 2004; accepted January 26, 2005.
Background Prolonged QRS duration (QRSd) is an important prognostic indicator for death and heart failure hospitalization in patients with systolic heart failure. The relationship of baseline QRSd to death and heart failure hospitalization in patients with sinus node dysfunction who require pacemaker therapy is unknown.
Methods and Results Baseline QRSd from 12-lead ECGs before pacemaker implantation were analyzed in the Mode Selection Trial (MOST), a 6-year, 2010-patient randomized trial of dual-chamber versus ventricular pacing in sinus node dysfunction. Baseline QRSd was
120 ms in 23.4% of patients and was associated with older age, lower ejection fraction, cardiomyopathy, and prior heart failure. Adjusted Cox models demonstrated baseline QRSd
120 ms was a strong independent predictor of death (hazard ratio [95% CI] 1.35 [1.07, 1.70], P=0.010) but not heart failure hospitalization. The risk of death increased with increased QRSd from 60 to 120 ms (P=0.002 and hazard ratio [95% CI] 1.14 [1.05, 1.23] for 10-ms increase in this range) after adjustment for other death predictors.
Conclusions Baseline QRSd
120 ms was associated with increased risk of death during pacemaker therapy for sinus node dysfunction.
Key Words: pacing heart failure mortality
This article has been cited by other articles:
![]() |
J. Marti-Almor, M. Cladellas, V. Bazan, C. Altaba, M. Guijo, J. Delclos, and J. Bruguera-Cortada Long-term mortality predictors in patients with chronic bifascicular block Europace, September 1, 2009; 11(9): 1201 - 1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Kavanagh, I. Belenkie, and H. J. Duff Transmural temporospatial left ventricular activation during pacing from different sites: potential implications for optimal pacing Cardiovasc Res, January 1, 2008; 77(1): 81 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Breidthardt, M. Christ, M. Matti, D. Schrafl, K. Laule, M. Noveanu, T. Boldanova, T. Klima, W. Hochholzer, A. P Perruchoud, et al. QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure Heart, September 1, 2007; 93(9): 1093 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Hayes, A. D. Sharma, J. C. Love, J. M. Herre, A. O. Leonen, P. J. Kudenchuk, and for the DAVID Investigators Abnormal Conduction Increases Risk of Adverse Outcomes From Right Ventricular Pacing J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1628 - 1633. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |